Lattice Biologics Launches AmnioVisc Amniotic Fluid Viscosupplement

Lattice Biologics launched AmnioVisc™, a minimally-processed amniotic fluid supplement for the treatment of osteoarthritis pain in all joints.

Results from a 275-patient study demonstrated lasting pain relief and fewer adverse events than hyaluronic acid viscosupplements, the current standard of care, including single-injection...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us